nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—TOP2A—Valrubicin—urinary bladder cancer	0.461	0.619	CbGbCtD
Ciprofloxacin—TOP2A—Epirubicin—urinary bladder cancer	0.0698	0.0937	CbGbCtD
Ciprofloxacin—TOP2A—Etoposide—urinary bladder cancer	0.0544	0.073	CbGbCtD
Ciprofloxacin—TOP2A—Doxorubicin—urinary bladder cancer	0.0371	0.0498	CbGbCtD
Ciprofloxacin—ABCB1—Mitomycin—urinary bladder cancer	0.0354	0.0475	CbGbCtD
Ciprofloxacin—CYP3A4—Thiotepa—urinary bladder cancer	0.0161	0.0216	CbGbCtD
Ciprofloxacin—CYP3A5—Etoposide—urinary bladder cancer	0.0112	0.015	CbGbCtD
Ciprofloxacin—ABCB1—Gemcitabine—urinary bladder cancer	0.0102	0.0137	CbGbCtD
Ciprofloxacin—CYP1A2—Fluorouracil—urinary bladder cancer	0.00996	0.0134	CbGbCtD
Ciprofloxacin—CYP1A2—Etoposide—urinary bladder cancer	0.00831	0.0112	CbGbCtD
Ciprofloxacin—ABCB1—Cisplatin—urinary bladder cancer	0.0074	0.00994	CbGbCtD
Ciprofloxacin—ABCB1—Etoposide—urinary bladder cancer	0.00727	0.00976	CbGbCtD
Ciprofloxacin—ABCB1—Doxorubicin—urinary bladder cancer	0.00496	0.00666	CbGbCtD
Ciprofloxacin—ABCB1—Methotrexate—urinary bladder cancer	0.0048	0.00645	CbGbCtD
Ciprofloxacin—CYP3A4—Etoposide—urinary bladder cancer	0.00436	0.00585	CbGbCtD
Ciprofloxacin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00297	0.00399	CbGbCtD
Ciprofloxacin—TOP2A—Epirubicin—Valrubicin—urinary bladder cancer	0.000509	0.125	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Valrubicin—urinary bladder cancer	0.000509	0.125	CbGdCrCtD
Ciprofloxacin—TOP2A—Doxorubicin—Valrubicin—urinary bladder cancer	0.000509	0.125	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Valrubicin—urinary bladder cancer	0.000509	0.125	CbGdCrCtD
Ciprofloxacin—TOP2A—Podofilox—Etoposide—urinary bladder cancer	0.000339	0.0835	CbGdCrCtD
Ciprofloxacin—TOP2A—Teniposide—Etoposide—urinary bladder cancer	0.000339	0.0835	CbGdCrCtD
Ciprofloxacin—TOP2A—Cytarabine—Gemcitabine—urinary bladder cancer	0.000191	0.047	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Epirubicin—urinary bladder cancer	0.000177	0.0436	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Epirubicin—urinary bladder cancer	0.000177	0.0436	CbGdCrCtD
Ciprofloxacin—TOP2A—Doxorubicin—Epirubicin—urinary bladder cancer	0.000177	0.0436	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Doxorubicin—urinary bladder cancer	0.000164	0.0403	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Doxorubicin—urinary bladder cancer	0.000164	0.0403	CbGdCrCtD
Ciprofloxacin—TOP2A—Epirubicin—Doxorubicin—urinary bladder cancer	0.000164	0.0403	CbGdCrCtD
Ciprofloxacin—TOP2A—Azacitidine—Gemcitabine—urinary bladder cancer	0.000137	0.0337	CbGdCrCtD
Ciprofloxacin—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	7.62e-05	0.00157	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	7.37e-05	0.00152	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	7.37e-05	0.00152	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	7.34e-05	0.00152	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	7.27e-05	0.0015	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	7.18e-05	0.00148	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	7.17e-05	0.00148	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—urinary bladder cancer	6.87e-05	0.00142	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	6.79e-05	0.0014	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	6.77e-05	0.0014	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	6.76e-05	0.00139	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	6.75e-05	0.00139	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	6.58e-05	0.00136	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	6.49e-05	0.00134	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.49e-05	0.00134	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	6.35e-05	0.00131	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	6.28e-05	0.0013	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	6.26e-05	0.00129	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	6.24e-05	0.00129	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	6.22e-05	0.00128	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	6.15e-05	0.00127	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	6.04e-05	0.00125	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—PTEN—urinary bladder cancer	6.01e-05	0.00124	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	5.97e-05	0.00123	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.96e-05	0.00123	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	5.89e-05	0.00122	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	5.89e-05	0.00122	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	5.81e-05	0.0012	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—EP300—urinary bladder cancer	5.73e-05	0.00118	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	5.72e-05	0.00118	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	5.69e-05	0.00117	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CCNE1—urinary bladder cancer	5.68e-05	0.00117	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	5.61e-05	0.00116	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TYMS—urinary bladder cancer	5.58e-05	0.00115	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	5.57e-05	0.00115	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	5.51e-05	0.00114	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	5.46e-05	0.00113	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	5.43e-05	0.00112	CbGpPWpGaD
Ciprofloxacin—Angiopathy—Methotrexate—urinary bladder cancer	5.36e-05	0.000264	CcSEcCtD
Ciprofloxacin—Immune system disorder—Methotrexate—urinary bladder cancer	5.34e-05	0.000263	CcSEcCtD
Ciprofloxacin—Dizziness—Fluorouracil—urinary bladder cancer	5.33e-05	0.000263	CcSEcCtD
Ciprofloxacin—Visual impairment—Epirubicin—urinary bladder cancer	5.33e-05	0.000262	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Methotrexate—urinary bladder cancer	5.32e-05	0.000262	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Doxorubicin—urinary bladder cancer	5.32e-05	0.000262	CcSEcCtD
Ciprofloxacin—Chills—Methotrexate—urinary bladder cancer	5.3e-05	0.000261	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	5.28e-05	0.00109	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—NAT1—urinary bladder cancer	5.28e-05	0.00109	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Cisplatin—urinary bladder cancer	5.23e-05	0.000258	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Epirubicin—urinary bladder cancer	5.23e-05	0.000258	CcSEcCtD
Ciprofloxacin—Alopecia—Methotrexate—urinary bladder cancer	5.22e-05	0.000257	CcSEcCtD
Ciprofloxacin—Vomiting—Gemcitabine—urinary bladder cancer	5.22e-05	0.000257	CcSEcCtD
Ciprofloxacin—Bradycardia—Doxorubicin—urinary bladder cancer	5.21e-05	0.000257	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.2e-05	0.00107	CbGpPWpGaD
Ciprofloxacin—Mental disorder—Methotrexate—urinary bladder cancer	5.18e-05	0.000255	CcSEcCtD
Ciprofloxacin—Rash—Gemcitabine—urinary bladder cancer	5.17e-05	0.000255	CcSEcCtD
Ciprofloxacin—Dermatitis—Gemcitabine—urinary bladder cancer	5.17e-05	0.000255	CcSEcCtD
Ciprofloxacin—Eye disorder—Epirubicin—urinary bladder cancer	5.17e-05	0.000255	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Etoposide—urinary bladder cancer	5.16e-05	0.000254	CcSEcCtD
Ciprofloxacin—Tinnitus—Epirubicin—urinary bladder cancer	5.15e-05	0.000254	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	5.15e-05	0.00106	CbGpPWpGaD
Ciprofloxacin—Erythema—Methotrexate—urinary bladder cancer	5.14e-05	0.000253	CcSEcCtD
Ciprofloxacin—Malnutrition—Methotrexate—urinary bladder cancer	5.14e-05	0.000253	CcSEcCtD
Ciprofloxacin—Haemoglobin—Doxorubicin—urinary bladder cancer	5.14e-05	0.000253	CcSEcCtD
Ciprofloxacin—Headache—Gemcitabine—urinary bladder cancer	5.14e-05	0.000253	CcSEcCtD
Ciprofloxacin—Flushing—Epirubicin—urinary bladder cancer	5.13e-05	0.000253	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Epirubicin—urinary bladder cancer	5.13e-05	0.000253	CcSEcCtD
Ciprofloxacin—Vomiting—Fluorouracil—urinary bladder cancer	5.13e-05	0.000253	CcSEcCtD
Ciprofloxacin—Rhinitis—Doxorubicin—urinary bladder cancer	5.13e-05	0.000253	CcSEcCtD
Ciprofloxacin—Hepatitis—Doxorubicin—urinary bladder cancer	5.11e-05	0.000252	CcSEcCtD
Ciprofloxacin—Haemorrhage—Doxorubicin—urinary bladder cancer	5.11e-05	0.000252	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.09e-05	0.00105	CbGpPWpGaD
Ciprofloxacin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	5.09e-05	0.000251	CcSEcCtD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	5.09e-05	0.00105	CbGpPWpGaD
Ciprofloxacin—Rash—Fluorouracil—urinary bladder cancer	5.09e-05	0.000251	CcSEcCtD
Ciprofloxacin—Dermatitis—Fluorouracil—urinary bladder cancer	5.08e-05	0.00025	CcSEcCtD
Ciprofloxacin—Pharyngitis—Doxorubicin—urinary bladder cancer	5.08e-05	0.00025	CcSEcCtD
Ciprofloxacin—Headache—Fluorouracil—urinary bladder cancer	5.05e-05	0.000249	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	5.05e-05	0.000249	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Doxorubicin—urinary bladder cancer	5.04e-05	0.000248	CcSEcCtD
Ciprofloxacin—Dysgeusia—Methotrexate—urinary bladder cancer	5.04e-05	0.000248	CcSEcCtD
Ciprofloxacin—Asthenia—Etoposide—urinary bladder cancer	5.03e-05	0.000248	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	5.03e-05	0.000248	CcSEcCtD
Ciprofloxacin—Angiopathy—Epirubicin—urinary bladder cancer	5.02e-05	0.000247	CcSEcCtD
Ciprofloxacin—Urethral disorder—Doxorubicin—urinary bladder cancer	5.01e-05	0.000247	CcSEcCtD
Ciprofloxacin—Immune system disorder—Epirubicin—urinary bladder cancer	4.99e-05	0.000246	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Epirubicin—urinary bladder cancer	4.98e-05	0.000245	CcSEcCtD
Ciprofloxacin—Back pain—Methotrexate—urinary bladder cancer	4.97e-05	0.000245	CcSEcCtD
Ciprofloxacin—Chills—Epirubicin—urinary bladder cancer	4.96e-05	0.000244	CcSEcCtD
Ciprofloxacin—Pruritus—Etoposide—urinary bladder cancer	4.96e-05	0.000244	CcSEcCtD
Ciprofloxacin—Arrhythmia—Epirubicin—urinary bladder cancer	4.94e-05	0.000243	CcSEcCtD
Ciprofloxacin—Visual impairment—Doxorubicin—urinary bladder cancer	4.93e-05	0.000243	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	4.9e-05	0.00101	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	4.9e-05	0.00101	CbGpPWpGaD
Ciprofloxacin—Alopecia—Epirubicin—urinary bladder cancer	4.88e-05	0.000241	CcSEcCtD
Ciprofloxacin—Nausea—Gemcitabine—urinary bladder cancer	4.87e-05	0.00024	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	4.86e-05	0.001	CbGpPWpGaD
Ciprofloxacin—Vomiting—Cisplatin—urinary bladder cancer	4.86e-05	0.00024	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—TERT—urinary bladder cancer	4.86e-05	0.001	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.85e-05	0.001	CbGpPWpGaD
Ciprofloxacin—Vision blurred—Methotrexate—urinary bladder cancer	4.85e-05	0.000239	CcSEcCtD
Ciprofloxacin—Mental disorder—Epirubicin—urinary bladder cancer	4.84e-05	0.000239	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Doxorubicin—urinary bladder cancer	4.84e-05	0.000238	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	4.83e-05	0.000997	CbGpPWpGaD
Ciprofloxacin—Rash—Cisplatin—urinary bladder cancer	4.82e-05	0.000238	CcSEcCtD
Ciprofloxacin—Dermatitis—Cisplatin—urinary bladder cancer	4.82e-05	0.000237	CcSEcCtD
Ciprofloxacin—Erythema—Epirubicin—urinary bladder cancer	4.81e-05	0.000237	CcSEcCtD
Ciprofloxacin—Malnutrition—Epirubicin—urinary bladder cancer	4.81e-05	0.000237	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.81e-05	0.000992	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Etoposide—urinary bladder cancer	4.79e-05	0.000236	CcSEcCtD
Ciprofloxacin—Nausea—Fluorouracil—urinary bladder cancer	4.79e-05	0.000236	CcSEcCtD
Ciprofloxacin—Eye disorder—Doxorubicin—urinary bladder cancer	4.78e-05	0.000236	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.77e-05	0.000235	CcSEcCtD
Ciprofloxacin—Tinnitus—Doxorubicin—urinary bladder cancer	4.77e-05	0.000235	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	4.77e-05	0.000984	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	4.77e-05	0.000984	CbGpPWpGaD
Ciprofloxacin—Anaemia—Methotrexate—urinary bladder cancer	4.75e-05	0.000234	CcSEcCtD
Ciprofloxacin—Flushing—Doxorubicin—urinary bladder cancer	4.75e-05	0.000234	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Doxorubicin—urinary bladder cancer	4.75e-05	0.000234	CcSEcCtD
Ciprofloxacin—Flatulence—Epirubicin—urinary bladder cancer	4.74e-05	0.000234	CcSEcCtD
Ciprofloxacin—Tension—Epirubicin—urinary bladder cancer	4.72e-05	0.000233	CcSEcCtD
Ciprofloxacin—Dysgeusia—Epirubicin—urinary bladder cancer	4.71e-05	0.000232	CcSEcCtD
Ciprofloxacin—Nervousness—Epirubicin—urinary bladder cancer	4.67e-05	0.00023	CcSEcCtD
Ciprofloxacin—Back pain—Epirubicin—urinary bladder cancer	4.65e-05	0.000229	CcSEcCtD
Ciprofloxacin—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	4.65e-05	0.000959	CbGpPWpGaD
Ciprofloxacin—Angiopathy—Doxorubicin—urinary bladder cancer	4.64e-05	0.000229	CcSEcCtD
Ciprofloxacin—Malaise—Methotrexate—urinary bladder cancer	4.64e-05	0.000228	CcSEcCtD
Ciprofloxacin—Dizziness—Etoposide—urinary bladder cancer	4.63e-05	0.000228	CcSEcCtD
Ciprofloxacin—Muscle spasms—Epirubicin—urinary bladder cancer	4.63e-05	0.000228	CcSEcCtD
Ciprofloxacin—Immune system disorder—Doxorubicin—urinary bladder cancer	4.62e-05	0.000228	CcSEcCtD
Ciprofloxacin—Vertigo—Methotrexate—urinary bladder cancer	4.62e-05	0.000228	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	4.61e-05	0.000227	CcSEcCtD
Ciprofloxacin—Leukopenia—Methotrexate—urinary bladder cancer	4.6e-05	0.000227	CcSEcCtD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	4.6e-05	0.000949	CbGpPWpGaD
Ciprofloxacin—Chills—Doxorubicin—urinary bladder cancer	4.59e-05	0.000226	CcSEcCtD
Ciprofloxacin—Arrhythmia—Doxorubicin—urinary bladder cancer	4.57e-05	0.000225	CcSEcCtD
Ciprofloxacin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	4.55e-05	0.000939	CbGpPWpGaD
Ciprofloxacin—Nausea—Cisplatin—urinary bladder cancer	4.54e-05	0.000224	CcSEcCtD
Ciprofloxacin—Vision blurred—Epirubicin—urinary bladder cancer	4.54e-05	0.000223	CcSEcCtD
Ciprofloxacin—Alopecia—Doxorubicin—urinary bladder cancer	4.52e-05	0.000223	CcSEcCtD
Ciprofloxacin—Cough—Methotrexate—urinary bladder cancer	4.49e-05	0.000221	CcSEcCtD
Ciprofloxacin—Mental disorder—Doxorubicin—urinary bladder cancer	4.48e-05	0.000221	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Epirubicin—urinary bladder cancer	4.46e-05	0.00022	CcSEcCtD
Ciprofloxacin—Convulsion—Methotrexate—urinary bladder cancer	4.46e-05	0.00022	CcSEcCtD
Ciprofloxacin—Vomiting—Etoposide—urinary bladder cancer	4.45e-05	0.000219	CcSEcCtD
Ciprofloxacin—Malnutrition—Doxorubicin—urinary bladder cancer	4.45e-05	0.000219	CcSEcCtD
Ciprofloxacin—Erythema—Doxorubicin—urinary bladder cancer	4.45e-05	0.000219	CcSEcCtD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.45e-05	0.000918	CbGpPWpGaD
Ciprofloxacin—Anaemia—Epirubicin—urinary bladder cancer	4.45e-05	0.000219	CcSEcCtD
Ciprofloxacin—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	4.44e-05	0.000916	CbGpPWpGaD
Ciprofloxacin—Agitation—Epirubicin—urinary bladder cancer	4.42e-05	0.000218	CcSEcCtD
Ciprofloxacin—Rash—Etoposide—urinary bladder cancer	4.42e-05	0.000218	CcSEcCtD
Ciprofloxacin—Dermatitis—Etoposide—urinary bladder cancer	4.41e-05	0.000217	CcSEcCtD
Ciprofloxacin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	4.41e-05	0.00091	CbGpPWpGaD
Ciprofloxacin—Headache—Etoposide—urinary bladder cancer	4.39e-05	0.000216	CcSEcCtD
Ciprofloxacin—Flatulence—Doxorubicin—urinary bladder cancer	4.39e-05	0.000216	CcSEcCtD
Ciprofloxacin—Chest pain—Methotrexate—urinary bladder cancer	4.38e-05	0.000216	CcSEcCtD
Ciprofloxacin—Arthralgia—Methotrexate—urinary bladder cancer	4.38e-05	0.000216	CcSEcCtD
Ciprofloxacin—Myalgia—Methotrexate—urinary bladder cancer	4.38e-05	0.000216	CcSEcCtD
Ciprofloxacin—Tension—Doxorubicin—urinary bladder cancer	4.37e-05	0.000215	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—ATM—urinary bladder cancer	4.37e-05	0.000901	CbGpPWpGaD
Ciprofloxacin—Dysgeusia—Doxorubicin—urinary bladder cancer	4.36e-05	0.000215	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	4.35e-05	0.000898	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDK4—urinary bladder cancer	4.35e-05	0.000897	CbGpPWpGaD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	4.35e-05	0.000214	CcSEcCtD
Ciprofloxacin—Malaise—Epirubicin—urinary bladder cancer	4.34e-05	0.000214	CcSEcCtD
Ciprofloxacin—Discomfort—Methotrexate—urinary bladder cancer	4.33e-05	0.000213	CcSEcCtD
Ciprofloxacin—Nervousness—Doxorubicin—urinary bladder cancer	4.32e-05	0.000213	CcSEcCtD
Ciprofloxacin—Vertigo—Epirubicin—urinary bladder cancer	4.32e-05	0.000213	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	4.32e-05	0.000891	CbGpPWpGaD
Ciprofloxacin—Syncope—Epirubicin—urinary bladder cancer	4.32e-05	0.000213	CcSEcCtD
Ciprofloxacin—Leukopenia—Epirubicin—urinary bladder cancer	4.31e-05	0.000212	CcSEcCtD
Ciprofloxacin—Back pain—Doxorubicin—urinary bladder cancer	4.31e-05	0.000212	CcSEcCtD
Ciprofloxacin—Muscle spasms—Doxorubicin—urinary bladder cancer	4.28e-05	0.000211	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.27e-05	0.000882	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	4.27e-05	0.000882	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	4.25e-05	0.000878	CbGpPWpGaD
Ciprofloxacin—Palpitations—Epirubicin—urinary bladder cancer	4.25e-05	0.00021	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	4.24e-05	0.000876	CbGpPWpGaD
Ciprofloxacin—Confusional state—Methotrexate—urinary bladder cancer	4.23e-05	0.000208	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Epirubicin—urinary bladder cancer	4.23e-05	0.000208	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—urinary bladder cancer	4.23e-05	0.000873	CbGpPWpGaD
Ciprofloxacin—Cough—Epirubicin—urinary bladder cancer	4.2e-05	0.000207	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Methotrexate—urinary bladder cancer	4.2e-05	0.000207	CcSEcCtD
Ciprofloxacin—Vision blurred—Doxorubicin—urinary bladder cancer	4.2e-05	0.000207	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	4.18e-05	0.000862	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	4.18e-05	0.000862	CbGpPWpGaD
Ciprofloxacin—Convulsion—Epirubicin—urinary bladder cancer	4.17e-05	0.000205	CcSEcCtD
Ciprofloxacin—Nausea—Etoposide—urinary bladder cancer	4.16e-05	0.000205	CcSEcCtD
Ciprofloxacin—Hypertension—Epirubicin—urinary bladder cancer	4.15e-05	0.000205	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	4.13e-05	0.000204	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Methotrexate—urinary bladder cancer	4.12e-05	0.000203	CcSEcCtD
Ciprofloxacin—Anaemia—Doxorubicin—urinary bladder cancer	4.12e-05	0.000203	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Methotrexate—urinary bladder cancer	4.11e-05	0.000202	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	4.11e-05	0.000848	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—TP53—urinary bladder cancer	4.1e-05	0.000847	CbGpPWpGaD
Ciprofloxacin—Arthralgia—Epirubicin—urinary bladder cancer	4.1e-05	0.000202	CcSEcCtD
Ciprofloxacin—Chest pain—Epirubicin—urinary bladder cancer	4.1e-05	0.000202	CcSEcCtD
Ciprofloxacin—Myalgia—Epirubicin—urinary bladder cancer	4.1e-05	0.000202	CcSEcCtD
Ciprofloxacin—Agitation—Doxorubicin—urinary bladder cancer	4.09e-05	0.000202	CcSEcCtD
Ciprofloxacin—Anxiety—Epirubicin—urinary bladder cancer	4.08e-05	0.000201	CcSEcCtD
Ciprofloxacin—Skin disorder—Methotrexate—urinary bladder cancer	4.08e-05	0.000201	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	4.07e-05	0.0002	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Methotrexate—urinary bladder cancer	4.06e-05	0.0002	CcSEcCtD
Ciprofloxacin—Discomfort—Epirubicin—urinary bladder cancer	4.05e-05	0.000199	CcSEcCtD
Ciprofloxacin—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	4.03e-05	0.000831	CbGpPWpGaD
Ciprofloxacin—Malaise—Doxorubicin—urinary bladder cancer	4.02e-05	0.000198	CcSEcCtD
Ciprofloxacin—Dry mouth—Epirubicin—urinary bladder cancer	4.01e-05	0.000197	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	4e-05	0.000826	CbGpPWpGaD
Ciprofloxacin—Vertigo—Doxorubicin—urinary bladder cancer	4e-05	0.000197	CcSEcCtD
Ciprofloxacin—Anorexia—Methotrexate—urinary bladder cancer	4e-05	0.000197	CcSEcCtD
Ciprofloxacin—Syncope—Doxorubicin—urinary bladder cancer	3.99e-05	0.000197	CcSEcCtD
Ciprofloxacin—Leukopenia—Doxorubicin—urinary bladder cancer	3.99e-05	0.000196	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	3.98e-05	0.000821	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	3.98e-05	0.000821	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	3.96e-05	0.000818	CbGpPWpGaD
Ciprofloxacin—Confusional state—Epirubicin—urinary bladder cancer	3.96e-05	0.000195	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	3.95e-05	0.000815	CbGpPWpGaD
Ciprofloxacin—Palpitations—Doxorubicin—urinary bladder cancer	3.93e-05	0.000194	CcSEcCtD
Ciprofloxacin—Oedema—Epirubicin—urinary bladder cancer	3.93e-05	0.000194	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.93e-05	0.000194	CcSEcCtD
Ciprofloxacin—Hypotension—Methotrexate—urinary bladder cancer	3.92e-05	0.000193	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Doxorubicin—urinary bladder cancer	3.91e-05	0.000193	CcSEcCtD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.91e-05	0.000806	CbGpPWpGaD
Ciprofloxacin—Cough—Doxorubicin—urinary bladder cancer	3.89e-05	0.000191	CcSEcCtD
Ciprofloxacin—Shock—Epirubicin—urinary bladder cancer	3.86e-05	0.00019	CcSEcCtD
Ciprofloxacin—Convulsion—Doxorubicin—urinary bladder cancer	3.86e-05	0.00019	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Epirubicin—urinary bladder cancer	3.85e-05	0.00019	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.85e-05	0.000189	CcSEcCtD
Ciprofloxacin—Hypertension—Doxorubicin—urinary bladder cancer	3.84e-05	0.000189	CcSEcCtD
Ciprofloxacin—Tachycardia—Epirubicin—urinary bladder cancer	3.83e-05	0.000189	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	3.82e-05	0.000188	CcSEcCtD
Ciprofloxacin—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	3.82e-05	0.000788	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—NAT1—urinary bladder cancer	3.82e-05	0.000788	CbGpPWpGaD
Ciprofloxacin—Skin disorder—Epirubicin—urinary bladder cancer	3.81e-05	0.000188	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Epirubicin—urinary bladder cancer	3.8e-05	0.000187	CcSEcCtD
Ciprofloxacin—Insomnia—Methotrexate—urinary bladder cancer	3.8e-05	0.000187	CcSEcCtD
Ciprofloxacin—Arthralgia—Doxorubicin—urinary bladder cancer	3.79e-05	0.000187	CcSEcCtD
Ciprofloxacin—Myalgia—Doxorubicin—urinary bladder cancer	3.79e-05	0.000187	CcSEcCtD
Ciprofloxacin—Chest pain—Doxorubicin—urinary bladder cancer	3.79e-05	0.000187	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—RB1—urinary bladder cancer	3.78e-05	0.00078	CbGpPWpGaD
Ciprofloxacin—Anxiety—Doxorubicin—urinary bladder cancer	3.78e-05	0.000186	CcSEcCtD
Ciprofloxacin—Paraesthesia—Methotrexate—urinary bladder cancer	3.77e-05	0.000186	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	3.76e-05	0.000185	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	3.76e-05	0.000776	CbGpPWpGaD
Ciprofloxacin—Discomfort—Doxorubicin—urinary bladder cancer	3.75e-05	0.000185	CcSEcCtD
Ciprofloxacin—Anorexia—Epirubicin—urinary bladder cancer	3.74e-05	0.000184	CcSEcCtD
Ciprofloxacin—Dyspnoea—Methotrexate—urinary bladder cancer	3.74e-05	0.000184	CcSEcCtD
Ciprofloxacin—Somnolence—Methotrexate—urinary bladder cancer	3.73e-05	0.000184	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	3.72e-05	0.000767	CbGpPWpGaD
Ciprofloxacin—Dry mouth—Doxorubicin—urinary bladder cancer	3.71e-05	0.000183	CcSEcCtD
Ciprofloxacin—Dyspepsia—Methotrexate—urinary bladder cancer	3.69e-05	0.000182	CcSEcCtD
Ciprofloxacin—Hypotension—Epirubicin—urinary bladder cancer	3.67e-05	0.000181	CcSEcCtD
Ciprofloxacin—Confusional state—Doxorubicin—urinary bladder cancer	3.66e-05	0.000181	CcSEcCtD
Ciprofloxacin—Decreased appetite—Methotrexate—urinary bladder cancer	3.65e-05	0.00018	CcSEcCtD
Ciprofloxacin—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	3.64e-05	0.000751	CbGpPWpGaD
Ciprofloxacin—Oedema—Doxorubicin—urinary bladder cancer	3.63e-05	0.000179	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.63e-05	0.000179	CcSEcCtD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.63e-05	0.000748	CbGpPWpGaD
Ciprofloxacin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.62e-05	0.000179	CcSEcCtD
Ciprofloxacin—Fatigue—Methotrexate—urinary bladder cancer	3.62e-05	0.000178	CcSEcCtD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.59e-05	0.000741	CbGpPWpGaD
Ciprofloxacin—Pain—Methotrexate—urinary bladder cancer	3.59e-05	0.000177	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.58e-05	0.000176	CcSEcCtD
Ciprofloxacin—Shock—Doxorubicin—urinary bladder cancer	3.58e-05	0.000176	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.56e-05	0.000176	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.56e-05	0.000175	CcSEcCtD
Ciprofloxacin—Insomnia—Epirubicin—urinary bladder cancer	3.55e-05	0.000175	CcSEcCtD
Ciprofloxacin—Tachycardia—Doxorubicin—urinary bladder cancer	3.55e-05	0.000175	CcSEcCtD
Ciprofloxacin—Skin disorder—Doxorubicin—urinary bladder cancer	3.53e-05	0.000174	CcSEcCtD
Ciprofloxacin—Paraesthesia—Epirubicin—urinary bladder cancer	3.53e-05	0.000174	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	3.51e-05	0.000173	CcSEcCtD
Ciprofloxacin—Dyspnoea—Epirubicin—urinary bladder cancer	3.5e-05	0.000173	CcSEcCtD
Ciprofloxacin—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	3.49e-05	0.000721	CbGpPWpGaD
Ciprofloxacin—Somnolence—Epirubicin—urinary bladder cancer	3.49e-05	0.000172	CcSEcCtD
Ciprofloxacin—Anorexia—Doxorubicin—urinary bladder cancer	3.46e-05	0.000171	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Methotrexate—urinary bladder cancer	3.46e-05	0.00017	CcSEcCtD
Ciprofloxacin—Dyspepsia—Epirubicin—urinary bladder cancer	3.46e-05	0.00017	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.43e-05	0.000169	CcSEcCtD
Ciprofloxacin—Decreased appetite—Epirubicin—urinary bladder cancer	3.41e-05	0.000168	CcSEcCtD
Ciprofloxacin—Hypotension—Doxorubicin—urinary bladder cancer	3.4e-05	0.000167	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.39e-05	0.000167	CcSEcCtD
Ciprofloxacin—Fatigue—Epirubicin—urinary bladder cancer	3.39e-05	0.000167	CcSEcCtD
Ciprofloxacin—Pain—Epirubicin—urinary bladder cancer	3.36e-05	0.000165	CcSEcCtD
Ciprofloxacin—Constipation—Epirubicin—urinary bladder cancer	3.36e-05	0.000165	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	3.36e-05	0.000692	CbGpPWpGaD
Ciprofloxacin—Urticaria—Methotrexate—urinary bladder cancer	3.33e-05	0.000164	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN2A—urinary bladder cancer	3.32e-05	0.000686	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	3.32e-05	0.000686	CbGpPWpGaD
Ciprofloxacin—Abdominal pain—Methotrexate—urinary bladder cancer	3.32e-05	0.000163	CcSEcCtD
Ciprofloxacin—Body temperature increased—Methotrexate—urinary bladder cancer	3.32e-05	0.000163	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	3.31e-05	0.000163	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	3.31e-05	0.000683	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.29e-05	0.00068	CbGpPWpGaD
Ciprofloxacin—Insomnia—Doxorubicin—urinary bladder cancer	3.29e-05	0.000162	CcSEcCtD
Ciprofloxacin—Paraesthesia—Doxorubicin—urinary bladder cancer	3.26e-05	0.000161	CcSEcCtD
Ciprofloxacin—Dyspnoea—Doxorubicin—urinary bladder cancer	3.24e-05	0.00016	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Epirubicin—urinary bladder cancer	3.24e-05	0.000159	CcSEcCtD
Ciprofloxacin—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.23e-05	0.000667	CbGpPWpGaD
Ciprofloxacin—Somnolence—Doxorubicin—urinary bladder cancer	3.23e-05	0.000159	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.21e-05	0.000158	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—TYMP—urinary bladder cancer	3.2e-05	0.000661	CbGpPWpGaD
Ciprofloxacin—Dyspepsia—Doxorubicin—urinary bladder cancer	3.2e-05	0.000158	CcSEcCtD
Ciprofloxacin—Decreased appetite—Doxorubicin—urinary bladder cancer	3.16e-05	0.000156	CcSEcCtD
Ciprofloxacin—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	3.15e-05	0.000649	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	3.14e-05	0.000648	CbGpPWpGaD
Ciprofloxacin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	3.14e-05	0.000155	CcSEcCtD
Ciprofloxacin—Fatigue—Doxorubicin—urinary bladder cancer	3.13e-05	0.000154	CcSEcCtD
Ciprofloxacin—Urticaria—Epirubicin—urinary bladder cancer	3.12e-05	0.000154	CcSEcCtD
Ciprofloxacin—Pain—Doxorubicin—urinary bladder cancer	3.11e-05	0.000153	CcSEcCtD
Ciprofloxacin—Constipation—Doxorubicin—urinary bladder cancer	3.11e-05	0.000153	CcSEcCtD
Ciprofloxacin—Abdominal pain—Epirubicin—urinary bladder cancer	3.1e-05	0.000153	CcSEcCtD
Ciprofloxacin—Body temperature increased—Epirubicin—urinary bladder cancer	3.1e-05	0.000153	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Methotrexate—urinary bladder cancer	3.09e-05	0.000152	CcSEcCtD
Ciprofloxacin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.06e-05	0.000631	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.04e-05	0.000627	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	3.04e-05	0.000627	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.02e-05	0.000622	CbGpPWpGaD
Ciprofloxacin—Asthenia—Methotrexate—urinary bladder cancer	3.01e-05	0.000148	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.99e-05	0.000148	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.97e-05	0.000146	CcSEcCtD
Ciprofloxacin—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	2.97e-05	0.000613	CbGpPWpGaD
Ciprofloxacin—Pruritus—Methotrexate—urinary bladder cancer	2.97e-05	0.000146	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—NAT2—urinary bladder cancer	2.89e-05	0.000597	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	2.89e-05	0.000597	CbGpPWpGaD
Ciprofloxacin—Hypersensitivity—Epirubicin—urinary bladder cancer	2.89e-05	0.000143	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—EP300—urinary bladder cancer	2.89e-05	0.000597	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	2.89e-05	0.000596	CbGpPWpGaD
Ciprofloxacin—Urticaria—Doxorubicin—urinary bladder cancer	2.89e-05	0.000142	CcSEcCtD
Ciprofloxacin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	2.88e-05	0.000595	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—NAT1—urinary bladder cancer	2.88e-05	0.000595	CbGpPWpGaD
Ciprofloxacin—Body temperature increased—Doxorubicin—urinary bladder cancer	2.87e-05	0.000142	CcSEcCtD
Ciprofloxacin—Abdominal pain—Doxorubicin—urinary bladder cancer	2.87e-05	0.000142	CcSEcCtD
Ciprofloxacin—Diarrhoea—Methotrexate—urinary bladder cancer	2.87e-05	0.000141	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	2.85e-05	0.000588	CbGpPWpGaD
Ciprofloxacin—Asthenia—Epirubicin—urinary bladder cancer	2.82e-05	0.000139	CcSEcCtD
Ciprofloxacin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.81e-05	0.00058	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CCND1—urinary bladder cancer	2.81e-05	0.000579	CbGpPWpGaD
Ciprofloxacin—Pruritus—Epirubicin—urinary bladder cancer	2.78e-05	0.000137	CcSEcCtD
Ciprofloxacin—Dizziness—Methotrexate—urinary bladder cancer	2.78e-05	0.000137	CcSEcCtD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.77e-05	0.000572	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN1A—urinary bladder cancer	2.72e-05	0.000561	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Epirubicin—urinary bladder cancer	2.69e-05	0.000132	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.68e-05	0.000132	CcSEcCtD
Ciprofloxacin—Vomiting—Methotrexate—urinary bladder cancer	2.67e-05	0.000131	CcSEcCtD
Ciprofloxacin—Rash—Methotrexate—urinary bladder cancer	2.65e-05	0.00013	CcSEcCtD
Ciprofloxacin—Dermatitis—Methotrexate—urinary bladder cancer	2.64e-05	0.00013	CcSEcCtD
Ciprofloxacin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	2.64e-05	0.000544	CbGpPWpGaD
Ciprofloxacin—Headache—Methotrexate—urinary bladder cancer	2.63e-05	0.00013	CcSEcCtD
Ciprofloxacin—Asthenia—Doxorubicin—urinary bladder cancer	2.61e-05	0.000128	CcSEcCtD
Ciprofloxacin—Dizziness—Epirubicin—urinary bladder cancer	2.6e-05	0.000128	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—EP300—urinary bladder cancer	2.58e-05	0.000533	CbGpPWpGaD
Ciprofloxacin—Pruritus—Doxorubicin—urinary bladder cancer	2.57e-05	0.000127	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	2.52e-05	0.00052	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—RRM2—urinary bladder cancer	2.5e-05	0.000516	CbGpPWpGaD
Ciprofloxacin—Vomiting—Epirubicin—urinary bladder cancer	2.5e-05	0.000123	CcSEcCtD
Ciprofloxacin—Nausea—Methotrexate—urinary bladder cancer	2.49e-05	0.000123	CcSEcCtD
Ciprofloxacin—Diarrhoea—Doxorubicin—urinary bladder cancer	2.49e-05	0.000123	CcSEcCtD
Ciprofloxacin—Rash—Epirubicin—urinary bladder cancer	2.48e-05	0.000122	CcSEcCtD
Ciprofloxacin—Dermatitis—Epirubicin—urinary bladder cancer	2.47e-05	0.000122	CcSEcCtD
Ciprofloxacin—Headache—Epirubicin—urinary bladder cancer	2.46e-05	0.000121	CcSEcCtD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.45e-05	0.000506	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	2.43e-05	0.000501	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.42e-05	0.000499	CbGpPWpGaD
Ciprofloxacin—Dizziness—Doxorubicin—urinary bladder cancer	2.4e-05	0.000118	CcSEcCtD
Ciprofloxacin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.37e-05	0.00049	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.36e-05	0.000488	CbGpPWpGaD
Ciprofloxacin—Nausea—Epirubicin—urinary bladder cancer	2.33e-05	0.000115	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—ENO2—urinary bladder cancer	2.31e-05	0.000478	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	2.31e-05	0.000478	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—TYMP—urinary bladder cancer	2.31e-05	0.000478	CbGpPWpGaD
Ciprofloxacin—Vomiting—Doxorubicin—urinary bladder cancer	2.31e-05	0.000114	CcSEcCtD
Ciprofloxacin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	2.3e-05	0.000475	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	2.3e-05	0.000475	CbGpPWpGaD
Ciprofloxacin—Rash—Doxorubicin—urinary bladder cancer	2.29e-05	0.000113	CcSEcCtD
Ciprofloxacin—Dermatitis—Doxorubicin—urinary bladder cancer	2.29e-05	0.000113	CcSEcCtD
Ciprofloxacin—Headache—Doxorubicin—urinary bladder cancer	2.28e-05	0.000112	CcSEcCtD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.26e-05	0.000467	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MYC—urinary bladder cancer	2.25e-05	0.000465	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	2.24e-05	0.000463	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.24e-05	0.000463	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.18e-05	0.000451	CbGpPWpGaD
Ciprofloxacin—Nausea—Doxorubicin—urinary bladder cancer	2.16e-05	0.000106	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.14e-05	0.000441	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	2.1e-05	0.000434	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—NAT2—urinary bladder cancer	2.09e-05	0.000432	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.07e-05	0.000426	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.06e-05	0.000425	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.97e-05	0.000406	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.91e-05	0.000395	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	1.89e-05	0.000391	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.87e-05	0.000387	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—NQO1—urinary bladder cancer	1.87e-05	0.000385	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TP53—urinary bladder cancer	1.85e-05	0.000382	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	1.81e-05	0.000373	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	1.79e-05	0.000369	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.78e-05	0.000366	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.78e-05	0.000366	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.75e-05	0.00036	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.74e-05	0.00036	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.71e-05	0.000354	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.68e-05	0.000346	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.67e-05	0.000345	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.67e-05	0.000345	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.62e-05	0.000335	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.62e-05	0.000335	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.6e-05	0.000329	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.58e-05	0.000327	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.58e-05	0.000326	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.56e-05	0.000321	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.46e-05	0.000302	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.45e-05	0.000298	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.43e-05	0.000295	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.43e-05	0.000295	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.41e-05	0.00029	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.4e-05	0.000288	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.39e-05	0.000288	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.38e-05	0.000285	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.37e-05	0.000283	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.36e-05	0.000281	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.35e-05	0.000278	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.35e-05	0.000278	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.34e-05	0.000277	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.34e-05	0.000276	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.26e-05	0.000261	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.26e-05	0.000261	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.26e-05	0.000261	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.26e-05	0.00026	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.22e-05	0.000253	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.15e-05	0.000237	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	0.000232	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.09e-05	0.000225	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.08e-05	0.000222	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.05e-05	0.000216	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.03e-05	0.000213	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.03e-05	0.000213	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.02e-05	0.000211	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.02e-05	0.00021	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.01e-05	0.000208	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.01e-05	0.000208	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1e-05	0.000207	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	9.9e-06	0.000204	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	9.84e-06	0.000203	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	9.77e-06	0.000202	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	9.73e-06	0.000201	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	9.72e-06	0.000201	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.62e-06	0.000199	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	9.13e-06	0.000188	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	8.49e-06	0.000175	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.4e-06	0.000173	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	8.12e-06	0.000168	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	8.06e-06	0.000166	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—TYMS—urinary bladder cancer	7.89e-06	0.000163	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.88e-06	0.000163	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	7.8e-06	0.000161	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	7.8e-06	0.000161	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7.78e-06	0.00016	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7.78e-06	0.00016	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.54e-06	0.000156	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GPX1—urinary bladder cancer	7.47e-06	0.000154	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	7.41e-06	0.000153	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	7.33e-06	0.000151	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	7.12e-06	0.000147	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PTEN—urinary bladder cancer	7.03e-06	0.000145	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	6.89e-06	0.000142	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.87e-06	0.000142	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	6.77e-06	0.00014	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—EP300—urinary bladder cancer	6.7e-06	0.000138	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.55e-06	0.000135	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	6.3e-06	0.00013	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.27e-06	0.000129	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	6.23e-06	0.000128	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	6.23e-06	0.000128	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	5.96e-06	0.000123	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	5.85e-06	0.000121	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	5.83e-06	0.00012	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.59e-06	0.000115	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	5.5e-06	0.000114	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.37e-06	0.000111	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.23e-06	0.000108	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	5.08e-06	0.000105	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.86e-06	0.0001	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.85e-06	0.0001	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.8e-06	9.92e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.8e-06	9.92e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.6e-06	9.5e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.52e-06	9.32e-05	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.46e-06	9.21e-05	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.4e-06	9.07e-05	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.29e-06	8.85e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.25e-06	8.76e-05	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.83e-06	7.91e-05	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—EP300—urinary bladder cancer	3.66e-06	7.55e-05	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.51e-06	7.24e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.44e-06	7.11e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.31e-06	6.83e-05	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.06e-06	6.32e-05	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.92e-06	6.02e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.71e-06	5.59e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.36e-06	4.88e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.25e-06	4.65e-05	CbGpPWpGaD
